Carbon Black (N110) - India CAS: 1333-86-4
Related Insights
34 Shipping Crossings Revitalize GCC Water Treatment Supply
The Gulf Cooperation Council now sees 34 daily shipping crossings, easing the logistical bottleneck that had left utilities scrambling for water treatment chemicals. With production steady but transport limited, the new capacity realigns supply with demand, enabling utilities to rebuild safety stock for peak summer months. Strategic warehousing at Sohar, Khor Fakkan and Jebel Ali will further restore procurement flexibility.
GLP-1 Peptide Manufacturing: TFA Supply Tightness After Solvay's European Closure
Trifluoroacetic acid has become a strategic procurement priority for GLP-1 peptide manufacturing following Solvay's European production closure. Pharmaceutical buyers should reassess sourcing strategies as Indian CDMO demand accelerates faster than supply growth.
Pharmaceutical Excipient SVHC Watch: What ECHA's July Update Means for Excipient Compliance
ECHA's upcoming SVHC candidate list update could introduce new compliance obligations for pharmaceutical excipient supply chains. Procurement and regulatory teams should prepare monitoring procedures to identify affected substances as soon as new candidate entries are published.
India DAP Tender Oversubscribed: Signals for Global Phosphate Prices
India’s latest DAP tender attracted record oversubscription, underscoring the country’s defensive buying stance. The move signals that global phosphate prices may stay high as demand in India remains robust. Analysts project a continued upward trend for DAP prices amid supply constraints.
Pharmaceutical Chemical Procurement Intelligence: June 24, 2026 Situation Report
Pharmaceutical procurement teams face an unusually complex H2 2026 environment shaped by GLP-1 manufacturing demand, excipient compliance changes, freight cost shifts, regulatory deadlines, and elevated drug shortage risk across critical therapeutic categories.
Drug Shortage Risk Intelligence: June 24 Status Update
Drug shortage risk remains elevated in H2 2026 despite easing Hormuz tensions. Pharmaceutical procurement teams should prioritize safety stock updates, secondary supplier qualification, and stronger force majeure protections to secure supply continuity into 2027.
Don't miss out on our updates! Subscribe to our newsletter now
We're committed to your privacy. Tradeasia uses the information you provide to us to contact you about our relevant content, products, and services. For more information, check out our privacy policy.